Norges Bank Portfolio holdings
Norges Bank, established in 1816 and headquartered in Oslo, Norway, serves as the central bank of Norway, responsible for monetary policy, issuing the Norwegian krone, and maintaining financial stability. Beyond its traditional central banking role, it oversees the management of the Government Pension Fund Global (often called the Norwegian Oil Fund), one of the world’s largest sovereign wealth funds, valued at over $1 trillion, which invests Norway’s oil and gas revenues in global equities, bonds, and real estate. The fund’s investment arm, Norges Bank Investment Management (NBIM), operates independently to ensure long-term wealth preservation for future generations, emphasizing sustainable and ethical investing practices. With its dual role, Norges Bank uniquely blends central banking duties with stewardship of a massive global investment portfolio.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$887M |
| 2 |
Apple
AAPL
|
+$653M |
| 3 |
Microsoft
MSFT
|
+$626M |
| 4 |
Tesla
TSLA
|
+$470M |
| 5 |
Amgen
AMGN
|
+$441M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$788M |
| 2 |
Cigna
CI
|
+$510M |
| 3 |
UBS Group
UBS
|
+$378M |
| 4 |
Morgan Stanley
MS
|
+$281M |
| 5 |
Autodesk
ADSK
|
+$241M |
Sector Composition
| 1 | Technology | 23.59% |
| 2 | Financials | 14.36% |
| 3 | Healthcare | 14.17% |
| 4 | Consumer Discretionary | 11.44% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Treace Medical Concepts
TMCI
$467M
| $10.3M | ﹤0.01% |
465,529
| – | – |
|
1527
PROS Holdings
PRO
$749M
| $10.3M | ﹤0.01% |
415,880
+224,935
| +118% | +$5.56M |
|
1528
FibroGen
FGEN
$46.4M
| $10.3M | ﹤0.01% |
31,564
| – | – |
|
1529
AAR Corp
AIR
$2.66B
| $10.3M | ﹤0.01% |
286,176
| – | – |
|
1530
Interparfums
IPAR
$3.72B
| $10.2M | ﹤0.01% |
135,640
-19,100
| -12% | -$1.44M |
|
1531
Nu Skin
NUS
$574M
| $10.2M | ﹤0.01% |
306,370
-52,450
| -15% | -$1.75M |
|
1532
NeoGenomics
NEO
$1.02B
| $10.2M | ﹤0.01% |
1,186,214
+119,917
| +11% | +$1.03M |
|
|
SWTX
1533
DELISTED
SpringWorks Therapeutics
SWTX
| $10.2M | ﹤0.01% |
357,694
-154,199
| -30% | -$4.4M |
|
1534
Progyny
PGNY
$1.98B
| $10.2M | ﹤0.01% |
275,270
-119,631
| -30% | -$4.43M |
|
1535
HNI Corp
HNI
$2.09B
| $10.2M | ﹤0.01% |
384,623
| – | – |
|
|
PMT
1536
PennyMac Mortgage Investment
PMT
$1.08B
| $10.2M | ﹤0.01% |
864,209
| – | – |
|
1537
Weibo
WB
$3B
| $10.1M | ﹤0.01% |
593,283
+319,269
| +117% | +$5.46M |
|
|
TWO
1538
Two Harbors Investment
TWO
$1.07B
| $10.1M | ﹤0.01% |
761,242
| – | – |
|
1539
Gates Industrial
GTES
$6.48B
| $10M | ﹤0.01% |
1,028,622
+414,839
| +68% | +$4.05M |
|
1540
JD.com
JD
$48B
| $10M | ﹤0.01% |
199,588
| – | – |
|
1541
Protolabs
PRLB
$1.18B
| $10M | ﹤0.01% |
275,542
| – | – |
|
1542
Agios Pharmaceuticals
AGIO
$2.1B
| $10M | ﹤0.01% |
353,502
-122,231
| -26% | -$3.46M |
|
1543
Allogene Therapeutics
ALLO
$253M
| $9.97M | ﹤0.01% |
923,009
| – | – |
|
1544
Encore Capital Group
ECPG
$1.01B
| $9.93M | ﹤0.01% |
218,351
+9,697
| +5% | +$441K |
|
1545
America Movil
AMX
$59.6B
| $9.88M | ﹤0.01% |
600,000
+200,000
| +50% | +$3.29M |
|
1546
Pacific Biosciences
PACB
$393M
| $9.85M | ﹤0.01% |
1,697,527
+448,468
| +36% | +$2.6M |
|
1547
NovaGold Resources
NG
$2.74B
| $9.83M | ﹤0.01% |
2,090,087
| – | – |
|
1548
Capitol Federal Financial
CFFN
$835M
| $9.83M | ﹤0.01% |
1,184,188
| – | – |
|
1549
Enerpac Tool Group
EPAC
$2.22B
| $9.82M | ﹤0.01% |
550,950
+49,503
| +10% | +$883K |
|
1550
Sabre
SABR
$698M
| $9.82M | ﹤0.01% |
1,906,715
-403,941
| -17% | -$2.08M |
|